1
Patients with positive margins should receive adjuvant radiotherapy for local control.
2
Women with higher AACCI are less likely to receive adjuvant chemotherapy.
3
The patient could not receive adjuvant chemotherapy because of her poor performance status.
4
The intra-arterial catheter devices were implanted in four patients in order to receive adjuvant chemotherapy.
5
There were no baseline differences between patients who did and those who did not receive adjuvant chemotherapy.
6
Patients selected to receive adjuvant irradiation were those for whom there was doubt as to the completeness of surgical resection.
7
The current study was designed to determine the proportion of patients ineligible to receive adjuvant cisplatin-based chemotherapy based on inadequate renal function alone.
8
Mean disease-free intervals for those who did and did not receive adjuvant therapy were equivalent at 2.4 years.
9
In the other three high-risk patients with residual tumour who did not receive adjuvant therapy, recurrence occurred early and Ki-67 LI predicted prognosis.
10
Patients and methods: Breast cancer patients scheduled to receive adjuvant chemotherapy (n = 61) completed comprehensive cognitive testing before and after treatment.
11
Kaplan-Meier survival curves were constructed to compare overall survival between patients who did and did not receive adjuvant external-beam radiation therapy (EBRT).
12
Women with stage II or III breast cancers who would ordinarily be advised to receive adjuvant chemotherapy should receive ovarian suppression with endocrine therapy.
13
Conclusions: This study has shown that being an FPC patient is a significant prognostic indicator for PC patients who undergo resection and receive adjuvant chemotherapy.
14
Current follow-up data continue to demonstrate a significant improvement in progression-free survival in favor of patients randomized to receive adjuvant chemotherapy (P = 0.0040).
15
Forty one patients underwent craniospinal irradiation and 27 patients received adjuvant chemotherapy.
16
Methodology: 30 patients received adjuvant chemotherapy following surgical resection for pancreatic cancer.
